Avidity Partners Management’s Alnylam Pharmaceuticals ALNY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
$8.35M Buy
2024
Q3
Sell
2024
Q2
$53.9M Sell
2024
Q1
$36.3M Buy
2022
Q4
Sell
2022
Q3
$57.7M Buy
2022
Q1
Sell
2021
Q4
$62.7M Sell
2021
Q3
$80.6M Buy
2021
Q2
$33.1M Sell
2021
Q1
$60.4M Buy